Business

An Overview of Aducanumab for the Treatment of Alzheimer Disease

Pamela Spicer, senior analyst with Datamonitor Healthcare, mentioned aducanumab is a once-monthly infusion with a 6-month titration schedule.

In a latest interview with Pharmacy Instances, Pamela Spicer, senior analyst with Datamonitor Healthcare, reviewed the approval of aducanumab and what pharmacists ought to learn about its use in sufferers with Alzheimer illness. Spicer mentioned aducanumab is a once-monthly infusion with a 6-month titration schedule. It has a number of notable hostile results, together with amyloid-related imaging abnormalities which must be monitored carefully.

https://www.pharmacytimes.com/view/an-overview-of-aducanumab-for-the-treatment-of-alzheimer-disease

Apkdownload

Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@interreviewed.com. The content will be deleted within 24 hours.

Related Articles

Back to top button